RecruitingNCT07018076

Candidate Clinical Correlate of Prognostic Outcome for TB Study

Studying Tuberculosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of California, San Francisco
Principal Investigator: Adithya Cattamanchi, MD
University of California San Francisco; University of California Irvine
Intervention: RS ratio(diagnostic_test)
Enrollment: 750 enrolled
Eligibility: 12 years · All sexes
Timeline: 2025 – 2027

Study locations (3)

Kisenyi Health Center, Kampala, Uganda
Mulago Outpatient Department, Kampala, Uganda
Hanoi Lung Hospital, Outpatient departments, Hanoi, Vietnam

Collaborators

University of California, Irvine · University of Colorado, Denver · National Institute of Allergy and Infectious Diseases (NIAID)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07018076 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials